Norges Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $996K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.95M | Sell |
|
|||||
|
2024
Q3 | $4.65M | Sell |
|
|||||
|
2024
Q2 | $4.03M | Sell |
|
|||||
|
2024
Q1 | $5.11M | Sell |
|
|||||
|
2023
Q4 | $13.3M | Buy |
|
|||||
|
2023
Q3 | $5.99M | Hold |
|
|||||
|
2023
Q2 | $5.96M | Sell |
|
|||||
|
2023
Q1 | $7.38M | Sell |
|
|||||
|
2022
Q4 | $13.2M | Buy |
|
|||||
|
2022
Q3 | $13.5M | Sell |
|
|||||
|
2022
Q2 | $21M | Buy |
|
|||||
|
2022
Q1 | $12.9M | Buy |
|
|||||
|
2021
Q4 | $9.94M | Sell |
|
|||||
|
2021
Q3 | $11.4M | Buy |
|
|||||
|
2021
Q2 | $2.71M | Hold |
|
|||||
|
2021
Q1 | $1.74M | Sell |
|
|||||
|
2020
Q4 | $2.61M | Sell |
|
|||||
|
2020
Q3 | $3.54M | Buy |
|
|||||
|
2020
Q2 | $2.59M | Buy |
|